NCT02005783View on ClinicalTrials.gov

Study of Danggui Buxue Decoction in Preventing Neutropenia

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

October 31, 2015

Conditions
Grade 3/4 NeutropeniaFebrile Neutropenia
Interventions
DRUG

DBD

DBD:one dose of medicine twice per day, orally

DRUG

Epirubicin

Epirubicin:90mg/m2, d1, q3w\*4

DRUG

Cyclophosphamide

Cyclophosphamide:600mg/m2, d1, q3w\*4

DRUG

Docetaxel

Docetaxel:75mg/m2, d1, q3w\*4

Trial Locations (1)

200025

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT02005783 - Study of Danggui Buxue Decoction in Preventing Neutropenia | Biotech Hunter | Biotech Hunter